Forte Biosciences (FBRX) Stock: Buy, Sell, or Hold?
FBRX - Forte Biosciences, Inc. Common Stock
$76.99
0.02 (0.03%)
▲
5d:
+0.12%
30d:
+0.44%
90d:
+258.59%
HOLD
MODERATE Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When FBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FBRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: FBRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: FBRX is currently trading at $76.99, which is considered extended relative to its 30-day fair value range of $76.82 to $76.94.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$76.82 -
$76.94
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($73.80)
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$76.82 -
$76.94
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.93
(1.2%)
Support & Resistance Levels
Support Level
$76.78
Resistance Level
$77.00
Current Trend
Strong Uptrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.52
Wall Street Target
$73.80
(-4.1%)
Share & Embed Analysis
Last updated: September 14, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$569 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$314 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
